Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials
| Autor: | Duffaud, F., Sleijfer, S., Litière, S., Ray-Coquard, I., Le Cesne, A., Papai, Z., Judson, I., Schöffski, P., Chawla, S.P., Dewji, R., Marreaud, S., Verweij, J., van der Graaf, W.T. |
|---|---|
| Zdroj: | In European Journal of Cancer November 2015 51(17):2615-2623 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect